#Africa

Nearly 600 people have died this year, far above the fatality rate of last year’s global outbreak.

Gilead and Gates lead in HIV grants. But the overall dip in philanthropic funding “raises red flags,” say FCAA report authors.

When given a choice, most women chose injectable cabotegravir over daily prevention pills.

Ending AIDS is a political and financial choice, UNAIDS states. Some countries see “extraordinary results,” but the U.S. faces challenges.

International Day Against Homophobia, Transphobia & Biphobia (#IDAHOBIT) is Wednesday, May 17.

The President’s Emergency Plan for AIDS Relief (PEPFAR) dramatically increased the number of people on lifesaving HIV meds globally.

Bill Gates and President Biden laud PEPFAR—which has saved 25 million lives—and urge its reauthorization this year.

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) will soon mark 20 years. It has already saved 25 million lives. [VIDEO]

Three curators discuss their recent exhibitions and the pivotal role of HIV and AIDS posters.

Health researchers are testing the flying bots in remote rural regions and congested urban areas alike.

A new global alliance launches to end AIDS in children by 2030. Currently, only half of children with HIV are on lifesaving treatment.

Generic cabotegravir, an every-other-month injectable to prevent HIV, will arrive in select countries. WHO and Health Gap have opinions.

The nation tops the list of countries that not only include trans people in their plans to end HIV but also back policy with funding.

As a Black leader, an HIV advocate and the father of a lesbian, Archbishop Desmond Tutu was one of us, writes AIDS United’s Jesse Milan.

A new study measures HIV and LGBTQ health equity and finds that HIV care providers are key health leaders. [VIDEO]